Scarica l'app Stockscreener
41.46
0.34%
-0.14
Dopo l'orario di chiusura:
41.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$41.60
Aprire:
$41.71
Volume 24 ore:
405.37K
Relative Volume:
0.81
Capitalizzazione di mercato:
$2.30B
Reddito:
$226.84M
Utile/perdita netta:
$3.55M
Rapporto P/E:
592.29
EPS:
0.07
Flusso di cassa netto:
$-12.02M
1 W Prestazione:
-1.00%
1M Prestazione:
+2.47%
6M Prestazione:
-24.77%
1 anno Prestazione:
-8.01%
Intervallo 1D:
$41.08
$42.42
Intervallo di 1 settimana:
$40.53
$43.57
Portata 52W:
$37.39
$63.00
Vericel Corp Stock (VCEL) Company Profile
Nome
Vericel Corp
Settore
Industria
Telefono
(734) 930-5555
Indirizzo
64 SIDNEY ST., CAMBRIDGE, MA
Confronta VCEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
41.46 | 2.30B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-09 | Iniziato | Canaccord Genuity | Buy |
| 2024-06-20 | Iniziato | TD Cowen | Buy |
| 2024-01-25 | Aggiornamento | Truist | Hold → Buy |
| 2023-08-08 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-11-09 | Downgrade | Truist | Buy → Hold |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2021-01-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Iniziato | Stephens | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2019-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Needham | Buy → Hold |
| 2018-08-08 | Reiterato | Needham | Buy |
| 2018-07-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Iniziato | Leerink Partners | Outperform |
| 2018-03-06 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Reiterato | Needham | Buy |
| 2018-03-05 | Reiterato | BTIG Research | Buy |
| 2017-06-21 | Iniziato | BTIG Research | Buy |
| 2017-03-13 | Reiterato | Needham | Buy |
| 2016-12-22 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-09 | Reiterato | Needham | Buy |
| 2016-04-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Vericel Corp Borsa (VCEL) Ultime notizie
Vericel at 2025 Truist Securities MedTech Conference: Growth Strategies Unveiled - Investing.com India
Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens - Defense World
Vericel (VCEL): Analyst Reiterates Overweight Rating with Stable Price Target | VCEL Stock News - GuruFocus
Handelsbanken Fonder AB Has $914,000 Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Rhumbline Advisers - Defense World
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 - Yahoo Finance
GAMMA Investing LLC Acquires 127,028 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Analysts - Defense World
3,924 Shares in Vericel Co. (NASDAQ:VCEL) Bought by Mackenzie Financial Corp - Defense World
Canaccord Genuity reiterates Buy rating on Vericel stock with $61 target - Investing.com
Bank of America Corp DE Sells 1,579 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel’s (VCEL) Overweight Rating Reiterated at Stephens - Defense World
What Analysts Are Saying About Vericel Stock - Benzinga
Vericel (VCEL) Maintains Overweight Rating by Stephens & Co. | V - GuruFocus
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Deutsche Bank AG - Defense World
Vericel Co. (NASDAQ:VCEL) Stock Position Cut by BNP Paribas Financial Markets - Defense World
Truist maintains Buy on Vericel shares with $52 target By Investing.com - Investing.com India
Truist maintains Buy on Vericel shares with $52 target - Investing.com
VCEL to Be Featured in Upcoming Investor Meetings | VCEL Stock N - GuruFocus
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $60.86 - Defense World
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare By Investing.com - Investing.com India
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare - Investing.com Australia
Transcript : Vericel Corporation Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 09 - marketscreener.com
VCEL: Upcoming Meeting and Market Insights | VCEL Stock News - GuruFocus
First Trust Advisors LP Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Vericel Corporation (NASDAQ:VCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustm - GuruFocus
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustment | VCEL Stock News - GuruFocus
Vericel Corp (VCEL) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Vericel Corp Ord earnings missed by $0.10, revenue fell short of estimates - Investing.com India
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Earnings call transcript: Vericel Corp Q1 2025 sees revenue growth, stock steady - Investing.com India
Vericel Q1 2025 slides: record revenue offset by widening losses, raises guidance - Investing.com South Africa
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Vericel (VCEL) Reports Slightly Lower Than Expected Q1 Revenue | VCEL Stock News - GuruFocus
Vericel's Q1 Loss Widens, Revenue Rises; 2025 Revenue Growth Outlook Reiterated - marketscreener.com
VCEL Updates Revenue and Profitability Outlook for 2023 | VCEL Stock News - GuruFocus
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Vericel Corp SEC 10-Q Report - TradingView
Vericel Corporation (VCEL): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey
Vericel Corp Reports Q1 2025 Earnings: EPS of -$0.23 Misses Estimates, Revenue of $52.6M Below Expectations - GuruFocus
Vericel Corporation Q1 2025 Financial Results - TradingView
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q1 Revenue $52.6M, vs. FactSet Est of $53.8M - marketscreener.com
Hsbc Holdings PLC Invests $405,000 in Vericel Co. (NASDAQ:VCEL) - The AM Reporter
Earnings To Watch: Vericel Corp (VCEL) Reports Q1 2025 Result - GuruFocus
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 - Barchart.com
Vericel’s 36% drop confirms InvestingPro’s January overvaluation warning By Investing.com - Investing.com
Vericel shareholders approve key incentive plans - Investing.com
Financial Health Report: Vericel Corp (VCEL)’s Ratios Tell a Tale - DWinneX
VCEL underperforms with a -0.26 decrease in share price - uspostnews.com
Vericel Corp Azioni (VCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vericel Corp Azioni (VCEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark | Chief Medical Officer |
Jun 02 '25 |
Sale |
40.09 |
10,000 |
400,900 |
66,237 |
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):